Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

SUTURA THERAPEUTICS LIMITED

Company number 12385038

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
15 Jun 2021 AD01 Registered office address changed from 47 Hamilton Square Birkenhead CH41 5AR to Alderley Park Congleton Road Macclesfield SK10 4TG on 15 June 2021
22 Mar 2021 MA Memorandum and Articles of Association
22 Mar 2021 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES01 ‐ Resolution of adoption of Articles of Association
11 Mar 2021 CS01 Confirmation statement made on 11 March 2021 with updates
09 Mar 2021 SH01 Statement of capital following an allotment of shares on 9 March 2021
  • GBP 1,009.86
15 Feb 2021 SH01 Statement of capital following an allotment of shares on 8 February 2021
  • GBP 1,000.71
15 Jan 2021 AP01 Appointment of Mr Lars Christian Wilde as a director on 30 December 2020
15 Jan 2021 AP01 Appointment of Mr Alex Smith as a director on 30 December 2020
19 Nov 2020 CS01 Confirmation statement made on 19 November 2020 with updates
15 Sep 2020 MA Memorandum and Articles of Association
15 Sep 2020 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
10 Sep 2020 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
14 Aug 2020 MA Memorandum and Articles of Association
14 Aug 2020 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
02 Mar 2020 AP01 Appointment of Mr James Julian Noble as a director on 24 February 2020
27 Feb 2020 AP01 Appointment of Mr Eduardo Bravo Fernandez De Araoz as a director on 27 February 2020
26 Feb 2020 SH01 Statement of capital following an allotment of shares on 13 February 2020
  • GBP 891.39
06 Feb 2020 PSC01 Notification of Keith Foster as a person with significant control on 17 January 2020
06 Feb 2020 PSC07 Cessation of Mark Granville Beards as a person with significant control on 17 January 2020
06 Feb 2020 SH01 Statement of capital following an allotment of shares on 17 January 2020
  • GBP 846.39
06 Feb 2020 AA01 Current accounting period shortened from 31 January 2021 to 31 December 2020
03 Jan 2020 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2020-01-03
  • GBP .01